Ed Barrett
October 2025
Develop and implement a comprehensive access realization plan for your biopharmaceutical company.
Optimize your company’s ability to support patients in “realizing access” to therapies.
Introduction
The landscape of market access for innovative therapies has become increasingly complex, creating an urgent need for pharmaceutical companies to enhance their Access Realization capabilities. A formulary win alone is often no longer sufficient to guarantee strong commercial returns. Something more is required – effective outward-facing pull-through strategy, education on reimbursement processes, and policy-level troubleshooting. This will help increase patient acquisition and prescription adherence.
Challenges such as perception issues that inhibit prescribing willingness, process issues like prior authorization denials and billing problems, and patient issues related to affordability and logistics contribute to a significant “Access Realization Gap” between potential and actual prescriptions. This gap necessitates that pharma companies create leading capabilities to bridge it, as Access Realization is currently lagging in the majority of companies.
This guide will help biopharmaceutical leaders develop a blueprint to close the access realization gap and enable their innovate therapies to reach patients in need.
Table of Contents
- Importance of Access Realization
- The Gap to Great
- The Role of a Market Access PLatform
- How to Evaluate a Market Access PLatform
- Planning Timeline for 2026 Readiness
- Why Choose AccessSync
- Key AccessSync Differentiators
Want to learn more?
Contact us or email to learn how we can help your team achieve your market access goals.
